Sabra Health Care REIT Details $277M YTD Acquisitions, $410M Pipeline, and $79M Dispositions
SBRA sits 18% above its 52-week low of $17.13.
Summary
Sabra Health Care REIT updated investors on its capital deployment, reporting $277 million in year-to-date acquisitions, a $410 million investment pipeline, and $79 million in opportunistic dispositions.
Key Events · Financing and Capital Events · SBRA
-
Significant Year-to-Date Acquisitions
Sabra has closed on $277 million in managed senior housing and skilled nursing investments year-to-date, with an estimated initial cash yield of 7.9%.
-
Robust Investment Pipeline
The company's pipeline of awarded investments stands at nearly $410 million, primarily in managed senior housing properties, with an estimated initial yield of 6.8%.
-
Opportunistic Asset Dispositions
In April, Sabra sold a portfolio of three skilled nursing properties for gross proceeds of $79 million, equating to a 6.8% lease yield, as part of its portfolio optimization.
-
Available At-The-Market (ATM) Program
The company has $353.4 million of availability under its at-the-market (ATM) equity offering program, providing ample liquidity for future financing.
Analysis · SBRA · Real Estate & Construction
This 8-K filing, an investor presentation, provides updated and specific figures on Sabra Health Care REIT's capital allocation strategy. The company has closed on $277 million in acquisitions year-to-date and has a robust pipeline of nearly $410 million in awarded investments, indicating active growth and portfolio expansion. Additionally, it details an opportunistic disposition of $79 million in April, which was previously highlighted in its Q1 2026 earnings. These figures demonstrate significant ongoing portfolio management and capital deployment, building on the strategic acquisitions mentioned in the recent 10-Q.
At the time of this filing, SBRA was trading at $20.28 on NASDAQ in the Real Estate & Construction sector, with a market capitalization of approximately $5.1B. The 52-week trading range was $17.13 to $21.28. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.